Literature DB >> 1398226

Helicobacter pylori and gastric cancer: correlation with gastritis, intestinal metaplasia, and tumour histology.

A Wee1, J Y Kang, M Teh.   

Abstract

This study aimed to examine the association between Helicobacter pylori, histological gastritis, and intestinal metaplasia in gastric cancers of different histological types. A total of 169 gastrectomy specimens received in one pathology department were studied. Altogether 156 were adenocarcinomas (intestinal type 87, diffuse type 50, mixed type 19). Gastritis occurred in 137 of 163 body specimens (84%) and in 126 of 131 antral specimens (96%). Its presence was unrelated to tumour histology. Atrophic gastritis was more common in both body and antral mucosa in intestinal type compared with diffuse type carcinoma. This was also true for intestinal metaplasia of the body, but not of the antral mucosa. H pylori was present in 101 of 163 (62%) body specimens and 56 of 131 (43%) antral specimens. In intestinal type carcinoma, H pylori was found in 52/84 (62%) body specimens and in 24/70 (34%) antral specimens, while the corresponding figures for diffuse type carcinoma were 29/48 (60%) and 17/38 (45%) respectively. Tumour histology therefore had no influence on the occurrence of H pylori. Tumour site had no effect on the presence or absence of gastritis, atrophic changes, intestinal metaplasia, or H pylori. While both H pylori and gastritis are associated with gastric cancer, the association is unrelated to tumour histology and may not be a causal one.

Entities:  

Mesh:

Year:  1992        PMID: 1398226      PMCID: PMC1379436          DOI: 10.1136/gut.33.8.1029

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  Helicobacter pylori and gastric carcinoma.

Authors:  R J Loffeld; I Willems; J A Flendrig; J W Arends
Journal:  Histopathology       Date:  1990-12       Impact factor: 5.087

3.  Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States.

Authors:  W Haenszel; M Kurihara
Journal:  J Natl Cancer Inst       Date:  1968-01       Impact factor: 13.506

Review 4.  A human model of gastric carcinogenesis.

Authors:  P Correa
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

Review 5.  The geography of cancer of the stomach.

Authors:  D Coggon; E D Acheson
Journal:  Br Med Bull       Date:  1984-10       Impact factor: 4.291

6.  Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China.

Authors:  D Forman; F Sitas; D G Newell; A R Stacey; J Boreham; R Peto; T C Campbell; J Li; J Chen
Journal:  Int J Cancer       Date:  1990-10-15       Impact factor: 7.396

7.  Campylobacter pylori. The organism and its clinical relevance.

Authors:  D Y Graham; D G Evans; D J Evans
Journal:  J Clin Gastroenterol       Date:  1989       Impact factor: 3.062

8.  Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas.

Authors:  J Parsonnet; D Vandersteen; J Goates; R K Sibley; J Pritikin; Y Chang
Journal:  J Natl Cancer Inst       Date:  1991-05-01       Impact factor: 13.506

9.  Intestinal and diffuse carcinoma of the stomach among the ethnic and dialect groups in Singapore.

Authors:  M Teh; Y S Lee
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

10.  Helicobacter pylori infection and the risk of gastric carcinoma.

Authors:  J Parsonnet; G D Friedman; D P Vandersteen; Y Chang; J H Vogelman; N Orentreich; R K Sibley
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

View more
  17 in total

1.  Species differentiation and identification in the genus of Helicobacter.

Authors:  Jie-Song Hua; Peng-Yuan Zheng; HO Bow
Journal:  World J Gastroenterol       Date:  1999-02       Impact factor: 5.742

2.  HELICOBACTER PYLORI AND GASTRIC CANCER: IS THERE A LINK?

Authors:  A C Anand; M Anand; P S Reddy; J R Bhardwaj
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  Helicobacter pylori and mucosal atrophy in patients with gastric cancer: a special study regarding the methods for detecting Helicobacter pylori.

Authors:  H Tabata; T Fuchigami; H Kobayashi; Y Sakai; M Nakanishi; K Tomioka; S Nakamura; M Fujishima
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

4.  Significance of Helicobacter pylori infection as a risk factor in gastric cancer: serological and histological studies.

Authors:  R Barreto-Zuñiga; M Maruyama; Y Kato; K Aizu; H Ohta; T Takekoshi; S F Bernal
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

5.  Alternative method for transporting and storing gastric biopsy cultures of Helicobacter pylori.

Authors:  A Savio
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

6.  Preliminary study suggests low incidence of gastric carcinoma in kelantan relates to low rate of helicobacter pylori infection.

Authors:  G Kaur; S M Raj
Journal:  Malays J Med Sci       Date:  2001-01

7.  A novel genetic polymorphism of inducible nitric oxide synthase is associated with an increased risk of gastric cancer.

Authors:  Jing Shen; Run-Tian Wang; Li-Wei Wang; Yao-Chu Xu; Xin-Ru Wang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Radical surgery for gastric cancer in Singapore.

Authors:  T K Ti
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  Development of a noninvasive method for detecting and monitoring the time course of Helicobacter pylori infection.

Authors:  Dougbeh C Nyan; Anthony R Welch; Andre Dubois; William G Coleman
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  General features of gastric carcinomas and comparison of HSP70 and NK cell immunoreactivity with prognostic factors.

Authors:  Ozlem Canöz; Olcay Belenli; Tahír E Patiroglu
Journal:  Pathol Oncol Res       Date:  2003-02-11       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.